{'fraction_non_alphanumeric': 0.0213089802130898, 'fraction_numerical': 0.0167427701674277, 'mean_word_length': 5.514851485148514, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Bone marrow scintigraphy with 111In-citrin in the diagnosis of hemoblastoses].

Bone marrow scintigraphy with 111In-citrin was used to investigate 55 patients with varying hemoblastoses. The high informative value of the method was shown in extended stages of polycythemia vera, lymphogranulomatosis, multiple myeloma and in leukemia. The method enables assessment of the morphofunctional state of the whole solid mass of the hemopoietic tissue. The data of bone marrow scintigraphy with 111In-citrin can be useful in determination of the disease stage, optimum scheme of its treatment, the therapeutic effectiveness control and prognosis of hemoblastoses.